D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-2.23%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$84.3B
AUM Growth
-$6.64B
Cap. Flow
-$7.19B
Cap. Flow %
-8.53%
Top 10 Hldgs %
14.62%
Holding
3,479
New
405
Increased
1,170
Reduced
1,077
Closed
350

Sector Composition

1 Technology 20.32%
2 Healthcare 13%
3 Consumer Discretionary 12.32%
4 Financials 8.62%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BRLSW icon
2776
Borealis Foods Inc. Warrant
BRLSW
$33.3K ﹤0.01%
300,000
SBCWW
2777
SBC Medical Group Holdings Incorporated Warrants
SBCWW
$2.39M
$32.1K ﹤0.01%
172,500
GSRTR
2778
GSR III Acquisition Corp. Right
GSRTR
$31.5K ﹤0.01%
21,428
NMRA icon
2779
Neumora Therapeutics
NMRA
$264M
$30.7K ﹤0.01%
+30,748
New +$30.7K
ANSCW
2780
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$4.04M
$30K ﹤0.01%
100,000
TAVIR
2781
Tavia Acquisition Corp. Right
TAVIR
$30K ﹤0.01%
200,000
AAM.WS
2782
AA Mission Acquisition Corp. Warrants, each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share
AAM.WS
$29.9K ﹤0.01%
450,000
ANVS icon
2783
Annovis Bio
ANVS
$45M
$28.2K ﹤0.01%
+18,789
New +$28.2K
BDTX icon
2784
Black Diamond Therapeutics
BDTX
$183M
$27.7K ﹤0.01%
17,854
+537
+3% +$832
CHARR
2785
Charlton Aria Acquisition Corporation Rights
CHARR
$27K ﹤0.01%
150,000
LEGT.WS
2786
Legato Merger Corp. III Redeemable Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share
LEGT.WS
$26.3K ﹤0.01%
136,100
BUJAR
2787
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$26K ﹤0.01%
100,000
RDACR
2788
Rising Dragon Acquisition Corp. Rights
RDACR
$24.2K ﹤0.01%
150,000
EUDAW icon
2789
EUDA Health Holdings Limited Warrant
EUDAW
$2.97M
$24K ﹤0.01%
200,000
DTSQR
2790
DT Cloud Star Acquisition Corporation Right
DTSQR
$23.7K ﹤0.01%
150,000
AEVAW
2791
Aeva Technologies, Inc. Warrants
AEVAW
$19.5M
$23.2K ﹤0.01%
294,000
BKHAR
2792
Black Hawk Acquisition Corporation Rights
BKHAR
$22.5K ﹤0.01%
15,000
GLACR
2793
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$22K ﹤0.01%
100,000
MACIW
2794
Melar Acquisition Corp. I Warrant
MACIW
$1.32M
$21.9K ﹤0.01%
162,500
TLRY icon
2795
Tilray
TLRY
$1.2B
$21.6K ﹤0.01%
+32,894
New +$21.6K
VSEEW
2796
VSee Health, Inc. Warrant
VSEEW
$422K
$21.5K ﹤0.01%
365,000
NUVB icon
2797
Nuvation Bio
NUVB
$1.14B
$21.3K ﹤0.01%
12,100
-35,300
-74% -$62.1K
OAKUR icon
2798
Oak Woods Acquisition Corporation Right
OAKUR
$20.8K ﹤0.01%
80,000
VLN.WS icon
2799
Valens Semiconductor Ltd. Warrants, each warrant to purchase one-half of one Ordinary Share
VLN.WS
$7.97M
$20.2K ﹤0.01%
447,342
EMCGR
2800
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
$19K ﹤0.01%
100,000